Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 9.12% and Operating profit at -18.05% over the last 5 years
2
With a fall in Net Sales of -13.69%, the company declared Very Negative results in Sep 25
3
Risky -
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
CNY 35,129 Million (Large Cap)
28.00
NA
3.00%
-0.11
3.63%
1.53
Revenue and Profits:
Net Sales:
2,587 Million
(Quarterly Results - Mar 2026)
Net Profit:
271 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.08%
0%
-4.08%
6 Months
-17.14%
0%
-17.14%
1 Year
-6.65%
0%
-6.65%
2 Years
-26.1%
0%
-26.1%
3 Years
-46.5%
0%
-46.5%
4 Years
-43.41%
0%
-43.41%
5 Years
-81.42%
0%
-81.42%
Changchun High-Tech Industry (Group) Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.12%
EBIT Growth (5y)
-18.05%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.58
Tax Ratio
12.15%
Dividend Payout Ratio
40.50%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
34.03%
ROE (avg)
21.87%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
2.27
EV to EBIT
20.92
EV to EBITDA
15.76
EV to Capital Employed
2.57
EV to Sales
3.52
PEG Ratio
NA
Dividend Yield
2.03%
ROCE (Latest)
12.31%
ROE (Latest)
8.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
2,587.30
2,997.50
-13.68%
Operating Profit (PBDIT) excl Other Income
361.40
759.80
-52.43%
Interest
13.10
8.00
63.75%
Exceptional Items
11.80
4.70
151.06%
Consolidate Net Profit
270.50
469.40
-42.37%
Operating Profit Margin (Excl OI)
139.70%
187.60%
-4.79%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -13.68% vs -4.96% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is -42.37% vs -47.36% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Change(%)
Net Sales
2,587.30
0.00
NA
Operating Profit (PBDIT) excl Other Income
361.40
0.00
NA
Interest
13.10
0.00
NA
Exceptional Items
11.80
0.00
NA
Consolidate Net Profit
270.50
0.00
NA
Operating Profit Margin (Excl OI)
139.70%
0.00%
NA
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
About Changchun High-Tech Industry (Group) Co., Ltd. 
Changchun High-Tech Industry (Group) Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






